Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EURO RELAX STUDY
2021-001503-33Phase 4Terminated
- Sponsor
- CHRU Nancy
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of rocuronium (2 arms), sponsored by CHRU Nancy. Primary endpoint: Incidence of intra-operative adverse events. Started May 2021; status: terminated.
02
Drugs
rocuronium
Beyond the preview
Go deeper on 2021-001503-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001503-33.